🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sue Murray

Ionis Pharmaceuticals (United States)

ORCID: 0000-0002-7302-624X

Social SciencesMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway”.

Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway

Cell Reports(2024)10.1016/j.celrep.2024.114746

N/A

0DataRank · unranked

27 citations

Dongyan Zhang, Yumin Ma, Rafael Calais Gaspar, Mario Kahn, Ali Nasiri +4 more

LipidSIM: Inferring mechanistic lipid biosynthesis perturbations from lipidomics with a flexible, low-parameter, Markov modeling framework

Metabolic Engineering(2024)10.1016/j.ymben.2024.01.004

N/A

0DataRank · unranked

2 citations

Sue Murray, Yang Li, Richard Lee, Audrey Low, Shruti Sasaki +6 more

CD47 antisense oligonucleotide treatment improves glucose homeostasis and alleviates dyslipidemia in aged male mice

Aging(2025)10.18632/aging.206343

N/A

0DataRank · unranked

0 citations

Alana Newcomb, Josephine Otuagomah, Sue Murray, Shuling Guo, Sheng Tong +3 more